Renewable chemicals have not received as much attention from policymakers as biofuels. While some states have started to shift their focus, there is still work to be done. BIO serves as a voice and we will continue to engage policymakers on the importance of renewable chemicals. #ABCsofClimateTech
Biotechnology Innovation Organization’s Post
More Relevant Posts
-
BIO members Ginkgo Bioworks, Inc. and Bayer are in a multi-year strategic partnership to accelerate the research and development of synthetic biological products for agriculture. #ABCsofClimateTech Learn more: https://lnkd.in/eSv4WWud
-
-
Explore #NaturesBuildingBlocks through heartfelt and inspiring videos that explore how biotechnology creates solutions to our greatest challenges: sustainability, health, and inequality. #NaturesBuildingBlocks series is BIO’s second film series produced by BBC StoryWorks. https://lnkd.in/e9YK-XAt
-
The FTC released an interim report criticizing the negative impact that PBMs have on prescription drug prices. Key findings show market concentration of PBMs and their disproportionate power over drug prices and patient access. Read the full report: https://lnkd.in/eXQuDpim
-
Congratulations to BIO member Eli Lilly and Company on last week's FDA approval for their treatment of early symptomatic Alzheimer's Disease!
Breaking News: The FDA approved a new amyloid-targeting therapy to treat adults with early symptomatic #AlzheimersDisease. Learn more: https://e.lilly/4bsaOPk
-
BIO events are not the only opportunity for BIO members to save. Members have access to the largest cost-saving program for the life sciences industry, BIO Business Solutions®. Become a member today and start saving. https://lnkd.in/eisSxMNH
-
-
Latest op-ed by National Organization for Rare Disorders CEO Pamela Gavin: Congress must renew the Rare Pediatric Disease Voucher Program to continue advancing treatments for rare childhood diseases. Read more: https://lnkd.in/eVaBYnTx
